• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳酸酐酶 IX 在肾肿瘤中的表达:与肿瘤类型和分级的相关性。

Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

机构信息

Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

出版信息

Am J Clin Pathol. 2010 Dec;134(6):873-9. doi: 10.1309/AJCPPPR57HNJMSLZ.

DOI:10.1309/AJCPPPR57HNJMSLZ
PMID:21088149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3778911/
Abstract

Carbonic anhydrase IX (CAIX), a hypoxia-induced protein, is expressed in some renal tumors. We evaluated its immunohistochemical expression in 317 primary and 42 metastatic renal neoplasms (186 clear cell, 52 papillary, 35 chromophobe, 47 unclassified, and 15 Xp11.2 translocation renal cell carcinomas [RCCs]; 26 oncocytomas; 2 metanephric adenomas; 1 urothelial carcinoma; 1 mixed epithelial and stromal tumor; and 1 angiomyolipoma); 7 neoplasms were unknown as to whether they were primary or metastatic. We also correlated expression with tumor type and grade. Variable staining was seen in clear cell, papillary, unclassified, and Xp11.2 translocation carcinomas. One chromophobe carcinoma had focal expression. No staining was seen with other tumors. An association was found between high expression and clear cell vs non-clear cell carcinomas with all cases (P < .01) and primary (P < .01) cases. An association between CAIX expression and grade (P < .01) in primary clear cell carcinomas was found. CAIX expression is more common in clear cell RCC than other renal tumor types and is associated with grade.

摘要

碳酸酐酶 IX(CAIX)是一种缺氧诱导蛋白,在一些肾肿瘤中表达。我们评估了其在 317 例原发性和 42 例转移性肾肿瘤(186 例透明细胞癌、52 例乳头状癌、35 例嫌色细胞癌、47 例未分类癌和 15 例 Xp11.2 易位肾细胞癌[RCC];26 例嗜酸细胞瘤;2 例后肾腺瘤;1 例尿路上皮癌;1 例混合上皮和间质肿瘤;和 1 例血管平滑肌脂肪瘤)中的免疫组织化学表达;7 例肿瘤未知是原发性还是转移性。我们还将表达与肿瘤类型和分级相关联。在透明细胞癌、乳头状癌、未分类癌和 Xp11.2 易位癌中观察到可变染色。1 例嫌色细胞癌有局灶性表达。其他肿瘤未见染色。高表达与透明细胞癌与非透明细胞癌(所有病例均 P <.01)和原发性病例(P <.01)之间存在关联。在原发性透明细胞癌中,CAIX 表达与分级之间存在关联(P <.01)。CAIX 表达在透明细胞 RCC 中比其他肾肿瘤类型更为常见,并且与分级相关。

相似文献

1
Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.碳酸酐酶 IX 在肾肿瘤中的表达:与肿瘤类型和分级的相关性。
Am J Clin Pathol. 2010 Dec;134(6):873-9. doi: 10.1309/AJCPPPR57HNJMSLZ.
2
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.膜性碳酸酐酶IX(CAIX)的异常表达与乳头状和透明细胞肾细胞癌的不良病程相关。
Urol Oncol. 2018 Dec;36(12):531.e19-531.e25. doi: 10.1016/j.urolonc.2018.08.015. Epub 2018 Oct 12.
3
[Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].[碳酸酐酶IX、PAX2和PAX8在肾上皮性肿瘤中的表达及其与临床病理特征的关系]
Zhonghua Bing Li Xue Za Zhi. 2013 Jul;42(7):442-5. doi: 10.3760/cma.j.issn.0529-5807.2013.07.003.
4
Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.转录因子Pax 2蛋白和跨膜酶复合物碳酸酐酶IX免疫反应性在成人肾上皮性肿瘤中的诊断意义
Am J Surg Pathol. 2009 Feb;33(2):241-7. doi: 10.1097/PAS.0b013e318181b828.
5
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.碳酸酐酶IX是晚期肾透明细胞癌生存的独立预测指标:对预后和治疗的意义。
Clin Cancer Res. 2003 Feb;9(2):802-11.
6
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.碳酸酐酶IX并非透明细胞肾细胞癌患者预后的独立预测指标。
J Clin Oncol. 2007 Oct 20;25(30):4757-64. doi: 10.1200/JCO.2007.12.1087.
7
Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.用于鉴别具有透明和乳头状特征的肾细胞癌的免疫组织化学检测组合
Pathol Oncol Res. 2015 Sep;21(4):893-9. doi: 10.1007/s12253-015-9898-7. Epub 2015 Feb 25.
8
Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.碳酸酐酶 9 在间皮瘤和转移性肺透明细胞肾细胞癌中表达。
Virchows Arch. 2012 Jan;460(1):89-93. doi: 10.1007/s00428-011-1178-7. Epub 2011 Dec 6.
9
Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.碳酸酐酶 IX、α-甲基酰基辅酶 A 消旋酶、细胞角蛋白 7 和半乳糖凝集素-3 在肾肿瘤评估中的作用:组织微阵列免疫组织化学研究。
Ann Diagn Pathol. 2013 Feb;17(1):58-62. doi: 10.1016/j.anndiagpath.2012.07.002. Epub 2012 Aug 14.
10
Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.碳酸酐酶 9(CA9)在多种肾上皮肿瘤亚型中的表达。
Histopathology. 2020 Oct;77(4):659-666. doi: 10.1111/his.14204. Epub 2020 Sep 12.

引用本文的文献

1
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma.体内发射的双特异性 T 细胞衔接器的格式调整增强了对肾细胞癌的疗效。
J Immunother Cancer. 2024 Jun 4;12(6):e008733. doi: 10.1136/jitc-2023-008733.
2
mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker.基于质谱法的带有蛋白酶可裂解且酸不稳定连接子的抗体-瑞喹莫德缀合物的生物分布分析
Front Pharmacol. 2023 Dec 6;14:1320524. doi: 10.3389/fphar.2023.1320524. eCollection 2023.
3
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal.

本文引用的文献

1
Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy.转移性肾细胞癌患者的治疗选择:确定有利于一线基于白细胞介素-2免疫疗法的特征。
Med Oncol. 2009;26 Suppl 1:18-22. doi: 10.1007/s12032-008-9148-x. Epub 2009 Jan 23.
2
Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.转录因子Pax 2蛋白和跨膜酶复合物碳酸酐酶IX免疫反应性在成人肾上皮性肿瘤中的诊断意义
Am J Surg Pathol. 2009 Feb;33(2):241-7. doi: 10.1097/PAS.0b013e318181b828.
3
囊性透明细胞肾细胞癌:形态学与分子学再评估
Cancers (Basel). 2023 Jun 26;15(13):3352. doi: 10.3390/cancers15133352.
4
Epigenetic mechanisms in metal carcinogenesis.金属致癌作用中的表观遗传机制。
Toxicol Rep. 2022 Apr 4;9:778-787. doi: 10.1016/j.toxrep.2022.03.037. eCollection 2022.
5
Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade.转移性透明细胞肾细胞癌的治疗管理:每十年一次的变革。
Cancers (Basel). 2022 Dec 17;14(24):6230. doi: 10.3390/cancers14246230.
6
Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors.嵌合抗原受体T细胞在实体瘤治疗中的疗效、安全性及挑战
Cancers (Basel). 2022 Dec 3;14(23):5983. doi: 10.3390/cancers14235983.
7
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.\[89Zr\]Zr-DFO-girentuximab 和\[18F\]FDG PET/CT 预测转移性透明细胞肾细胞癌患者的观察等待时间。
Clin Cancer Res. 2023 Feb 1;29(3):592-601. doi: 10.1158/1078-0432.CCR-22-0921.
8
Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells.免疫检查点阻断通过 PD-L1 增强了基于 CD28 的抗碳酸酐酶 IX 嵌合抗原受体 T 细胞,而不是基于 4-1BB 的抗碳酸酐酶 IX 嵌合抗原受体 T 细胞。
Int J Mol Sci. 2022 May 13;23(10):5448. doi: 10.3390/ijms23105448.
9
Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy.碳酸酐酶IX:癌症免疫治疗的新靶点。
Cancers (Basel). 2022 Mar 9;14(6):1392. doi: 10.3390/cancers14061392.
10
Role of CAIX Expression in Conventional Renal Cell Carcinomas as a Diagnostic Marker and its Prognostic Importance.碳酸酐酶IX(CAIX)表达在传统型肾细胞癌中作为诊断标志物的作用及其预后意义。
Indian J Surg Oncol. 2021 Apr;12(Suppl 1):79-84. doi: 10.1007/s13193-020-01076-9. Epub 2020 Jul 20.
Cancer statistics, 2008.
2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
4
Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.碳酸酐酶IX并非透明细胞肾细胞癌患者预后的独立预测指标。
J Clin Oncol. 2007 Oct 20;25(30):4757-64. doi: 10.1200/JCO.2007.12.1087.
5
Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.细胞角蛋白7、KIT和PAX2的免疫组织化学分析:在嫌色细胞癌鉴别诊断中的价值
Am J Clin Pathol. 2007 Feb;127(2):225-9. doi: 10.1309/9KWEA4W9Y94D1AEE.
6
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours.跨膜碳酸酐酶IX和XII在卵巢肿瘤中的表达
Histopathology. 2006 Dec;49(6):594-602. doi: 10.1111/j.1365-2559.2006.02523.x.
7
The pathology of renal epithelial neoplasms.肾上皮性肿瘤的病理学
Semin Oncol. 2006 Oct;33(5):534-43. doi: 10.1053/j.seminoncol.2006.06.009.
8
An immunohistochemical approach to the differential diagnosis of renal tumors.一种用于肾肿瘤鉴别诊断的免疫组织化学方法。
Semin Diagn Pathol. 2005 Feb;22(1):51-68. doi: 10.1053/j.semdp.2005.11.004.
9
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.碳酸酐酶IX的表达可预测肾癌白细胞介素2治疗的结果。
Clin Cancer Res. 2005 May 15;11(10):3714-21. doi: 10.1158/1078-0432.CCR-04-2019.
10
The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.免疫组化标志物在肾肿瘤鉴别诊断中的应用价值。
Clin Lab Med. 2005 Jun;25(2):247-57. doi: 10.1016/j.cll.2005.01.004.